The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II
The paper presents the main provisions of the updated 2019 EULAR/ERA-EDTA guidelines for the lupus nephritis (LN) therapy, which have been prepared by an international group of rheumatologists, nephrologists, morphologists, and pediatricians. Part 2 of the article discusses additional therapy, monit...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2021-02-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1093 |
_version_ | 1797876692168998912 |
---|---|
author | N. L. Kozlovskaya S. K. Solovyev E. A. Aseeva T. V. Popkova T. A. Panafidina E. L. Nasonov A. M. Lila A. A. Mesnyankina N. Yu. Nikishina |
author_facet | N. L. Kozlovskaya S. K. Solovyev E. A. Aseeva T. V. Popkova T. A. Panafidina E. L. Nasonov A. M. Lila A. A. Mesnyankina N. Yu. Nikishina |
author_sort | N. L. Kozlovskaya |
collection | DOAJ |
description | The paper presents the main provisions of the updated 2019 EULAR/ERA-EDTA guidelines for the lupus nephritis (LN) therapy, which have been prepared by an international group of rheumatologists, nephrologists, morphologists, and pediatricians. Part 2 of the article discusses additional therapy, monitoring, and prognosis for LN, and the management of patients with end-stage renal failure and antiphospholipid syndrome. Attention is paid to the problem of LN and pregnancy, as well as to the management of pediatric patients with kidney damage. |
first_indexed | 2024-04-10T02:06:39Z |
format | Article |
id | doaj.art-ad037bdef3f84450bdb0d2dfadb97703 |
institution | Directory Open Access Journal |
issn | 1996-7012 2310-158X |
language | Russian |
last_indexed | 2024-04-10T02:06:39Z |
publishDate | 2021-02-01 |
publisher | IMA-PRESS LLC |
record_format | Article |
series | Современная ревматология |
spelling | doaj.art-ad037bdef3f84450bdb0d2dfadb977032023-03-13T08:39:28ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2021-02-0115191410.14412/1996-7012-2021-1-9-142316The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part IIN. L. Kozlovskaya0S. K. Solovyev1E. A. Aseeva2T. V. Popkova3T. A. Panafidina4E. L. Nasonov5A. M. Lila6A. A. Mesnyankina7N. Yu. Nikishina8ФГАОУ ВО «Российский университет дружбы народов»; ГБУЗ г. Москвы «Городская клиническая больница им. А.К. Ерамишанцева Департамента здравоохранения города Москвы»ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»; Институт профессионального образования ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский университет)ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»The paper presents the main provisions of the updated 2019 EULAR/ERA-EDTA guidelines for the lupus nephritis (LN) therapy, which have been prepared by an international group of rheumatologists, nephrologists, morphologists, and pediatricians. Part 2 of the article discusses additional therapy, monitoring, and prognosis for LN, and the management of patients with end-stage renal failure and antiphospholipid syndrome. Attention is paid to the problem of LN and pregnancy, as well as to the management of pediatric patients with kidney damage.https://mrj.ima-press.net/mrj/article/view/1093волчаночный нефритклинические рекомендации |
spellingShingle | N. L. Kozlovskaya S. K. Solovyev E. A. Aseeva T. V. Popkova T. A. Panafidina E. L. Nasonov A. M. Lila A. A. Mesnyankina N. Yu. Nikishina The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II Современная ревматология волчаночный нефрит клинические рекомендации |
title | The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II |
title_full | The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II |
title_fullStr | The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II |
title_full_unstemmed | The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II |
title_short | The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II |
title_sort | 2019 updated eular era edta guidelines for the management of lupus nephritis expert comments part ii |
topic | волчаночный нефрит клинические рекомендации |
url | https://mrj.ima-press.net/mrj/article/view/1093 |
work_keys_str_mv | AT nlkozlovskaya the2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT sksolovyev the2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT eaaseeva the2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT tvpopkova the2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT tapanafidina the2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT elnasonov the2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT amlila the2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT aamesnyankina the2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT nyunikishina the2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT nlkozlovskaya 2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT sksolovyev 2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT eaaseeva 2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT tvpopkova 2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT tapanafidina 2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT elnasonov 2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT amlila 2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT aamesnyankina 2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii AT nyunikishina 2019updatedeulareraedtaguidelinesforthemanagementoflupusnephritisexpertcommentspartii |